TP53 and cancer: Within this set, 84 mutations in 81 genes were previously identified in the same cell line using bulk genomic DNA, including mutations in multiple key cancer driver genes such as TP53 and PIK3CA. We focused our analysis on this set of 84 validated mutations to establish how known somatically acquired mutations can be differentially distributed amongst individual cells.